Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
210000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for the 16th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
発行・処分する株式数
210,000 new shares (number of shares delivered from 1 May 2026)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Existing Shares and Increase
+2.60%Rate of increase
8,078,200 shares8,288,200Shares
Approximately 2.6% (210,000 new shares / 8,078,200 issued shares as of 30 April 2026)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment clause. The exercise price was ¥511 on 1 May 2026, ¥465 or ¥473 from 7 to 14 May, and ¥425 from 15 to 19 May. The adjustment floor is not disclosed.
Number of Stock Acquisition Rights
17,000 issued in total, 5,150 unexercised as of 30 April 2026, and 3,050 unexercised at present
Most recent equity financing
16th Series of Stock Acquisition Rights issued on 1 August 2025, with EVO FUND as the allottee (17,000 issued in total)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 16th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 210,000 new shares (number of shares delivered from 1 May 2026) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | Approximately 2.6% (210,000 new shares / 8,078,200 issued shares as of 30 April 2026) |
| Total number of issued shares | 8,078,200 shares (as of 30 April 2026) → 8,288,200 shares (if all 210,000 new shares are reflected)（Approximately 2.6%） |
| Exercise price | Subject to an exercise price adjustment clause. The exercise price was ¥511 on 1 May 2026, ¥465 or ¥473 from 7 to 14 May, and ¥425 from 15 to 19 May. The adjustment floor is not disclosed. |
| Number of Stock Acquisition Rights | 17,000 issued in total, 5,150 unexercised as of 30 April 2026, and 3,050 unexercised at present |
| Most recent equity financing | 16th Series of Stock Acquisition Rights issued on 1 August 2025, with EVO FUND as the allottee (17,000 issued in total) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This reports the fact of the substantial exercise; the company has not stated the reason for the exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.